Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2013 Filed Mar 5, 2013 21:55 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 46,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-13-006657 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-third of restricted stock units granted on March 3, 2009. The balance of the award is scheduled to vest on the fifth anniversary of the grant date. Read SEC document |
| February 27, 2013 Filed Feb 27, 2013 21:08 UTC |
Caforio GiovanniPres., US Pharmaceuticals
|
SaleCommon Stock, $0.10 par value | 12,150 | $37.08 | $450,522.00 |
DisclosureSEC source: 0001225208-13-005725 · doc4.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Pres., US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,850.018 Read SEC document |
| February 26, 2013 Filed Feb 27, 2013 21:08 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.44 | $364,400.00 |
DisclosureSEC source: 0001225208-13-005726 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.33 to $36.74, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2013 Filed Feb 27, 2013 21:08 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.71 | $367,100.00 |
DisclosureSEC source: 0001225208-13-005726 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.44 to $36.98, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2013 Filed Feb 21, 2013 23:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.67 | $366,700.00 |
DisclosureSEC source: 0001225208-13-005021 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.59 to $36.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2013 Filed Feb 20, 2013 21:12 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionOption (right to buy) · Derivative | 17,710 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001225208-13-004681 · doc4.xml · derivative · entry 6 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 17,710 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document |
| February 20, 2013 Filed Feb 20, 2013 21:12 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionOption (right to buy) · Derivative | 22,598 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001225208-13-004681 · doc4.xml · derivative · entry 5 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 22,598 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007. Read SEC document |
| February 20, 2013 Filed Feb 20, 2013 21:12 UTC |
Caldarella Joseph CSVP & Controller
|
SaleCommon Stock, $0.10 par value | 37,585 | $36.87 | $1,385,758.95 |
DisclosureSEC source: 0001225208-13-004681 · doc4.xml · nonDerivative · entry 3 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,382 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.87 to $36.89, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2013 Filed Feb 20, 2013 21:12 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 17,710 | $22.73 | $402,548.30 |
DisclosureSEC source: 0001225208-13-004681 · doc4.xml · nonDerivative · entry 2 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2013 Filed Feb 20, 2013 21:12 UTC |
Caldarella Joseph CSVP & Controller
|
Exercise / conversionCommon Stock, $0.10 par value | 22,598 | $27.01 | $610,371.98 |
DisclosureSEC source: 0001225208-13-004681 · doc4.xml · nonDerivative · entry 1 Caldarella Joseph C · CIK 0001341069 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2013 Filed Feb 21, 2013 23:06 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.87 | $368,700.00 |
DisclosureSEC source: 0001225208-13-005021 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,091,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.70 to $36.98, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2013 Filed Feb 13, 2013 22:09 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.15 | $361,500.00 |
DisclosureSEC source: 0001225208-13-003973 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.05 to $36.45, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2013 Filed Feb 13, 2013 22:09 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.68 | $366,800.00 |
DisclosureSEC source: 0001225208-13-003973 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.56 to $36.85, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2013 Filed Feb 11, 2013 21:08 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
Exercise / conversionOption (right to buy) · Derivative | 16,875 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0001225208-13-003597 · doc4.xml · derivative · entry 4 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 16,875 shares Expires 2014-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. Read SEC document |
| February 11, 2013 Filed Feb 11, 2013 21:08 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
SaleCommon Stock, $0.10 par value | 10,364 | $36.97 | $383,157.08 |
DisclosureSEC source: 0001225208-13-003597 · doc4.xml · nonDerivative · entry 3 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,307.97 Read SEC document |
| February 11, 2013 Filed Feb 11, 2013 21:08 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
SaleCommon Stock, $0.10 par value | 4,900 | $36.98 | $181,202.00 |
DisclosureSEC source: 0001225208-13-003597 · doc4.xml · nonDerivative · entry 2 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,671.97 Read SEC document |
| February 11, 2013 Filed Feb 11, 2013 21:08 UTC |
Elicker John ESVP Pub Affairs & Inv Relation
|
Exercise / conversionCommon Stock, $0.10 par value | 16,875 | $28.11 | $474,356.25 |
DisclosureSEC source: 0001225208-13-003597 · doc4.xml · nonDerivative · entry 1 Elicker John E · CIK 0001554788 · SVP Pub Affairs & Inv Relation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,571.97 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionOption (right to buy) · Derivative | 48,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 11 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 48,333 shares Expires 2014-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $22.73 | $0.00 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 10 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,795 Underlying: Common Stock, $0.10 par value · 70,000 shares Expires 2016-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionExecutive Option (right to buy) · Derivative | 147,749 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · derivative · entry 9 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 147,749 shares Expires 2019-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
SaleCommon Stock, $0.10 par value | 224,705 | $36.79 | $8,266,896.95 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 4 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,429 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.73 to $36.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 48,333 | $28.11 | $1,358,640.63 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 70,000 | $22.73 | $1,591,100.00 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 2 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2013 Filed Feb 11, 2013 21:08 UTC |
SIGAL ELLIOTDirector · EVP, CSO & President R&D
|
Exercise / conversionCommon Stock, $0.10 par value | 147,749 | $17.51 | $2,587,084.99 |
DisclosureSEC source: 0001225208-13-003595 · doc4.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · Director · EVP, CSO & President R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 21:30 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.42 | $364,200.00 |
DisclosureSEC source: 0001225208-13-003509 · doc4.xml · nonDerivative · entry 2 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F3 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.29 to $36.76, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2013 Filed Feb 8, 2013 21:30 UTC |
CORNELIUS JAMES MDirector
|
SaleCommon Stock, $0.10 par value | 10,000 | $36.51 | $365,100.00 |
DisclosureSEC source: 0001225208-13-003509 · doc4.xml · nonDerivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012. F2 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.41 to $36.70, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 05, 2013 Filed Feb 5, 2013 21:18 UTC |
LEUNG SANDRAGeneral Counsel & Secretary
|
Exercise / conversionOption (right to buy) · Derivative | 19,310 | $0.00 Strike: $23.14 | $0.00 |
DisclosureSEC source: 0001225208-13-002980 · doc4.xml · derivative · entry 4 LEUNG SANDRA · CIK 0001199294 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 19,310 shares Expires 2013-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2003. Read SEC document |
| February 05, 2013 Filed Feb 5, 2013 21:18 UTC |
LEUNG SANDRAGeneral Counsel & Secretary
|
SaleCommon Stock, $0.10 par value | 16,780 | $36.87 | $618,678.60 |
DisclosureSEC source: 0001225208-13-002980 · doc4.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,478 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.86 to $36.88, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 05, 2013 Filed Feb 5, 2013 21:18 UTC |
LEUNG SANDRAGeneral Counsel & Secretary
|
Exercise / conversionCommon Stock, $0.10 par value | 19,310 | $23.14 | $446,833.40 |
DisclosureSEC source: 0001225208-13-002980 · doc4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:06 UTC |
CAMPBELL LEWIS BDirector
|
Exercise / conversionOption (right to buy) · Derivative | 3,500 | $0.00 Strike: $25.51 | $0.00 |
DisclosureSEC source: 0001225208-13-002963 · doc4.xml · derivative · entry 5 CAMPBELL LEWIS B · CIK 0001176437 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,500 shares Expires 2013-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 6, 2003. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:06 UTC |
CAMPBELL LEWIS BDirector
|
SaleCommon Stock, $0.10 par value | 3,500 | $36.77 | $128,695.00 |
DisclosureSEC source: 0001225208-13-002963 · doc4.xml · nonDerivative · entry 2 CAMPBELL LEWIS B · CIK 0001176437 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:06 UTC |
CAMPBELL LEWIS BDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 3,500 | $25.51 | $89,285.00 |
DisclosureSEC source: 0001225208-13-002963 · doc4.xml · nonDerivative · entry 1 CAMPBELL LEWIS B · CIK 0001176437 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionOption (right to buy) · Derivative | 15,663 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · derivative · entry 7 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 15,663 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionOption (right to buy) · Derivative | 21,049 | $0.00 Strike: $22.14 | $0.00 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · derivative · entry 6 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 21,049 shares Expires 2018-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionOption (right to buy) · Derivative | 19,500 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · derivative · entry 5 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 19,500 shares Expires 2014-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
SaleCommon Stock, $0.10 par value | 50,300 | $36.67 | $1,844,501.00 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · nonDerivative · entry 4 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,125 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.63 to $36.70, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionCommon Stock, $0.10 par value | 15,663 | $27.01 | $423,057.63 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · nonDerivative · entry 3 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionCommon Stock, $0.10 par value | 19,500 | $28.11 | $548,145.00 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · nonDerivative · entry 2 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2013 Filed Feb 5, 2013 21:18 UTC |
von Autenried PaulSVP & CIO
|
Exercise / conversionCommon Stock, $0.10 par value | 21,049 | $22.14 | $466,024.86 |
DisclosureSEC source: 0001225208-13-002981 · doc4.xml · nonDerivative · entry 1 von Autenried Paul · CIK 0001524143 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:06 UTC |
CAMPBELL LEWIS BDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002963 · doc4.xml · derivative · entry 4 CAMPBELL LEWIS B · CIK 0001176437 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,444.39 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:06 UTC |
CORNELIUS JAMES MDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002964 · doc4.xml · derivative · entry 1 CORNELIUS JAMES M · CIK 0001198959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,589.54 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:08 UTC |
FREEH LOUIS JDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002967 · doc4.xml · derivative · entry 1 FREEH LOUIS J · CIK 0001279230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,660.55 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:11 UTC |
GLIMCHER LAURIE H M.D.Director
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002971 · doc4.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,186.27 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:11 UTC |
GROBSTEIN MICHAELDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002972 · doc4.xml · derivative · entry 1 GROBSTEIN MICHAEL · CIK 0001222342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,434.78 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:18 UTC |
LACY ALAN JDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002982 · doc4.xml · derivative · entry 1 LACY ALAN J · CIK 0001200232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,475.13 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:18 UTC |
SATO VICKI LDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002983 · doc4.xml · derivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,500.44 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:19 UTC |
Storch Gerald LDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002984 · doc4.xml · derivative · entry 1 Storch Gerald L · CIK 0001205004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,118.72 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:19 UTC |
WEST TOGO D JRDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002985 · doc4.xml · derivative · entry 1 WEST TOGO D JR · CIK 0001117026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,128.5 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:19 UTC |
Williams R SandersDirector
|
GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002986 · doc4.xml · derivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,335.71 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 31, 2013 Filed Jan 31, 2013 21:54 UTC |
DANIELS BRIANSVP Global Dev & Med Affairs
|
SaleCommon Stock, $0.10 par value | 12,000 | $36.22 | $434,640.00 |
DisclosureSEC source: 0001225208-13-002612 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010.041 F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.20 to $36.27, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.